首站-论文投稿智能助手
典型文献
HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models
文献摘要:
HOXA transcript at the distal tip (HOTTIP), a newly identified long noncoding RNA, has been shown to exhibit anti-inflammatory effects and inhibit oxygen-glucose deprivation-induced neuronal apoptosis. However, its role in Parkinson's disease (PD) remains unclear. 1-Methyl-4-phenylpyridium (MPP+) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were used to establish PD models in SH-SY5Y and BV2 cells and in C57BL/6 male mice, respectively. In vitro, after HOTTIP knockdown by sh-HOTTIP transfection, HOTTIP and FOXO1 overexpression promoted SH-SY5Y apoptosis, BV2 microglial activation, proinflammatory cytokine expression, and nuclear factor kappa-B and NACHT, LRR and PYD domains-containing protein 3 inflammasome activation. Overexpression of miR-615-3p inhibited MPP+-induced neuronal apoptosis and microglial inflammation and ameliorated HOTTIP- and FOXO1-mediated nerve injury and inflammation. In vivo, HOTTIP knockdown alleviated motor dysfunction in PD mice and reduced neuronal apoptosis and microglial activation in the substantia nigra. These findings suggest that inhibition of HOTTIP mitigates neuronal apoptosis and microglial activation in PD models by modulating miR-615-3p/FOXO1. This study was approved by the Ethics Review Committee of the Affiliated Hospital of Qingdao University, China (approval No. UDX-2018-042) in June 2018.
文献关键词:
作者姓名:
Peng Lun
作者机构:
Department of Neurosurgery,the Affiliated Hospital of Qingdao University,Qingdao,Shandong Province,China;Department of Neurosurgery,Laiyang People's Hospital,Yantai,Shandong Province,China;Department of Endocrine and Metabolic Diseases,the Affiliated Hospital of Qingdao University,Qingdao,Shandong Province,China;Emergency Department,the Affiliated Hospital of Qingdao University,Qingdao,Shandong Province,China
引用格式:
[1]Peng Lun-.HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models)[J].中国神经再生研究(英文版),2022(04):887-897
A类:
phenylpyridium,UDX
B类:
HOTTIP,downregulation,reduces,neuronal,damage,microglial,activation,Parkinson,disease,mouse,models,HOXA,transcript,distal,tip,newly,identified,long,noncoding,has,been,shown,exhibit,effects,oxygen,glucose,deprivation,induced,apoptosis,However,its,role,remains,unclear,Methyl,MPP+,methyl,tetrahydropyridine,MPTP,were,used,establish,SH,SY5Y,BV2,cells,C57BL,male,mice,respectively,In,vitro,after,knockdown,by,transfection,FOXO1,overexpression,promoted,proinflammatory,cytokine,nuclear,kappa,NACHT,LRR,PYD,domains,containing,protein,inflammasome,Overexpression,miR,3p,inhibited,inflammation,ameliorated,mediated,nerve,injury,vivo,alleviated,motor,dysfunction,reduced,substantia,nigra,These,findings,suggest,that,inhibition,mitigates,modulating,This,study,was,approved,Ethics,Review,Committee,Affiliated,Hospital,Qingdao,University,China,approval,No,June
AB值:
0.592546
相似文献
CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson’s disease
Lu Lin;Mao Hengxu;Zhou Miaomiao;Lin Yuwan;Dai Wei;Qiu Jiewen;Xiao Yousheng;Mo Mingshu;Zhu Xiaoqin;Wu Zhuohua;Pei Zhong;Guo Wenyuan;Xu Pingyi;Chen Xiang-Department of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China;Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China;Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
Ya-li Zhang;Wen-xin Zhang;Jue-qian Yan;Ye-lin Tang;Wen-jing Jia;Zheng-wei Xu;Ming-jiang Xu;Nipon Chattipakorn;Yi Wang;Jian-peng Feng;Zhi-guo Liu;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai 264005,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Zhuji Biomedicine Institute,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhuji 311800,China;Cardiac Electrophysiology Research and Training Center,Faculty of Medicine,Chiang Mai University,Chiang Mai 50200,Thailand;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
CDDO-Im ameliorates osteoarthritis and inhibits chondrocyte apoptosis in mice via enhancing Nrf2-dependent autophagy
Jian Dong;Kai-jia Zhang;Gao-cai Li;Xing-ren Chen;Jia-jia Lin;Jia-wei Li;Zhong-yang Lv;Zhao-zhi Deng;Jin Dai;Wangsen Cao;Qing Jiang-Division of Sports Medicine and Adult Reconstructive Surgery,Department of Orthopedic Surgery,State Key Laboratory of Pharmaceutical Biotechnology,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China;Department of Orthopedics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Critical Care Medicine,Jinling Hospital,School of Medicine,Nanjing University Medical School,Nanjing 210003,China;Center for Organ Fibrosis and Remodeling Research,Jiangsu Key Lab of Molecular Medicine,Nanjing University Medical School,Nanjing 210093,China
Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
Zhou Zhu;Liang-feng Liu;Cheng-fu Su;Jia Liu;Benjamin Chun-Kit Tong;Ashok lyaswamy;Senthilkumar Krishnamoorthi;Sravan Gopalkrishnashetty Sreenivasmurthy;Xin-jie Guan;Yu-xuan Kan;Wen-jian Xie;Chen-liang Zhao;King-ho Cheung;Jia-hong Lu;Jie-qiong Tan;Hong-jie Zhang;Ju-xian Song;Min Li-Mr.&Mrs.Ko Chi-Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;institute for Research and Continuing Education,Hong Kong Baptist University,Shenzhen 518057,China;Limin Pharmaceutical Factory,Livzon Group Limited,Shaoguan 512028,China;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR,China;Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases,School of Life Sciences,Central South University,Changsha 410078,China;Medical College of Acupuncture-Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。